Australia markets open in 6 hours 58 minutes

Elicio Therapeutics, Inc. (ELTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.93-0.24 (-2.94%)
As of 11:52AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 83.91M
Enterprise value 78.73M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)17.23
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-33.58%
S&P500 52-week change 323.76%
52-week high 312.77
52-week low 32.96
50-day moving average 38.87
200-day moving average 36.87

Share statistics

Avg vol (3-month) 355.49k
Avg vol (10-day) 315.75k
Shares outstanding 510.27M
Implied shares outstanding 610.67M
Float 85.43M
% held by insiders 129.51%
% held by institutions 14.04%
Shares short (15 May 2024) 490.44k
Short ratio (15 May 2024) 41.96
Short % of float (15 May 2024) 41.12%
Short % of shares outstanding (15 May 2024) 40.88%
Shares short (prior month 15 Apr 2024) 461.91k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 302 June 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-95.54%
Return on equity (ttm)-1,288.17%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -37.83M
Net income avi to common (ttm)-38.99M
Diluted EPS (ttm)-3.82
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.85M
Total cash per share (mrq)1.16
Total debt (mrq)6.67M
Total debt/equity (mrq)137.00%
Current ratio (mrq)2.37
Book value per share (mrq)0.48

Cash flow statement

Operating cash flow (ttm)-36.68M
Levered free cash flow (ttm)-20.73M